DeepMed Research

Innovaderm Research Inc

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Phase 2

Active, not recruiting

Conditions: Chronic Hand Eczema

Interventions: Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg
Drug: Placebo

First Posted Date: 2024-02-28

Last Posted Date: 2025-04-17

Lead Sponsor: Innovaderm Research Inc.

Target Recruit Count: 84

Registration Number: NCT06283550

Locations: 🇨🇦
INNO-6052 Site 12, Fredericton, New Brunswick, Canada
🇨🇦
INNO-6052 Site 13, Cobourg, Ontario, Canada
🇨🇦
INNO-6052 Site 11, Montréal, Quebec, Canada

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects With Discoid Lupus Erythematosus

Phase 2

Recruiting

Conditions: Discoid Lupus Erythematosus

Interventions: Drug: Ruxolitinib 1.5% cream
Procedure: Application without occlusion in Area 1
Procedure: Application under occlusion at night in Area 1
Procedure: Application under occlusion at night in Area 2
Procedure: Application without occlusion in Area 2

First Posted Date: 2024-02-15

Last Posted Date: 2025-03-24

Lead Sponsor: Innovaderm Research Inc.

Target Recruit Count: 20

Registration Number: NCT06261021

Locations: 🇨🇦
INNO-6051 Site 03, Fredericton, New Brunswick, Canada
🇨🇦
Innovaderm Research Inc., Montréal, Quebec, Canada

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Recruiting

Conditions: Chronic Hand Eczema
Plaque Psoriasis
Palmoplantar Pustulosis
Atopic Dermatitis
Acne
Hidradenitis Suppurativa

Interventions: Procedure: Blood samples collection
Procedure: Oral samples collection
Procedure: Hair samples collection
Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)
Procedure: Skin surface material samples
Procedure: Drainage fluid samples collection
Procedure: Stool samples collection

First Posted Date: 2023-08-16

Last Posted Date: 2025-01-31

Lead Sponsor: Innovaderm Research Inc.

Target Recruit Count: 500

Registration Number: NCT05994976

Locations: 🇨🇦
Innovaderm Research Inc., Montréal, Quebec, Canada

Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects With Atopic Dermatitis

Phase 4

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: Triamcinolone Acetonide (Aristocort® C)
Drug: Vehicle

First Posted Date: 2023-05-06

Last Posted Date: 2025-03-26

Lead Sponsor: Innovaderm Research Inc.

Target Recruit Count: 20

Registration Number: NCT05844618

Locations: 🇨🇦
Innovaderm Research Inc., Montréal, Quebec, Canada

Study to Assess the Reliability of PASI Scoring Using Digital-Based Images

Active, not recruiting

Conditions: Plaque Psoriasis

Interventions: Other: In-Person and Remote Disease Assessment

First Posted Date: 2023-04-28

Last Posted Date: 2025-04-30

Lead Sponsor: Innovaderm Research Inc.

Target Recruit Count: 34

Registration Number: NCT05835843

Locations: 🇨🇦
Innovaderm Research, Montréal, Quebec, Canada

Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab

Phase 4

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: Abrocitinib

First Posted Date: 2022-11-02

Last Posted Date: 2025-03-28

Lead Sponsor: Innovaderm Research Inc.

Target Recruit Count: 24

Registration Number: NCT05602207

Locations: 🇺🇸
Inno-6050 Site 22, Birmingham, Alabama, United States
🇺🇸
Inno-6050 Site 13, Fountain Valley, California, United States
🇺🇸
Inno-6050 Site 21, Miami Lakes, Florida, United States

and more 9 locations

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

Phase 4

Withdrawn

Conditions: Psoriasis Vulgaris
Active Psoriatic Arthritis

Interventions: Drug: Bimekizumab

First Posted Date: 2022-08-12

Last Posted Date: 2023-03-15

Lead Sponsor: Innovaderm Research Inc.

Registration Number: NCT05499416

Development of a Method to Measure mRNA Levels in Skin Samples

Not Applicable

Completed

Conditions: Healthy
Psoriasis
Atopic Dermatitis Eczema

Interventions: Other: Skin squame collection
Other: Tape strip collection
Other: Tape strip and skin biopsy collection

First Posted Date: 2020-09-03

Last Posted Date: 2020-09-04

Lead Sponsor: Innovaderm Research Inc.

Target Recruit Count: 61

Registration Number: NCT04537468

Locations: 🇨🇦
Innovaderm Research, Inc., Montreal, Quebec, Canada

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

Phase 4

Completed

Conditions: Dermatitis, Atopic

Interventions: Drug: Placebo ointment
Drug: Crisaborole 2%

First Posted Date: 2019-03-08

Last Posted Date: 2021-08-24

Lead Sponsor: Innovaderm Research Inc.

Target Recruit Count: 31

Registration Number: NCT03868098

Locations: 🇨🇦
Innovaderm Research Inc., Montréal, Quebec, Canada

Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers

Not Applicable

Completed

Conditions: Delayed Type Hypersensitivity

Interventions: Drug: Placebo
Drug: Prednisone

First Posted Date: 2018-08-10

Last Posted Date: 2020-07-17

Lead Sponsor: Innovaderm Research Inc.

Target Recruit Count: 54

Registration Number: NCT03625219

Locations: 🇨🇦
Innovaderm Research Inc., Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy